Otros idiomas Sol-Gel Technologies Ltd.

Acciones

SLGL

IL0011417206

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:01 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,8896 ^USD	+3,32 %		-5,36 %	-19,49 %

13/03	Sol-Gel Technologies Ltd. Resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
29/02	Sol-Gel Technologies Ltd. Elige a Yuval Yanai como director externo	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	01/04
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	13/03
Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	29/02
Sol-Gel Technologies Ltd. Screens First Patient for SGT-610 Phase 3 Study	30/11
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	30/11
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	28/11
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	20/11
Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board	20/11
Sol-Gel Technologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	09/11
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	30/08/23
Sol-Gel Technologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	10/08/23
Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors	27/07/23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	21/06/23
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	14/06/23
Sol-Gel Technologies, Searchlight Pharma Sign Licensing Deals for 2 Dermatology Drugs	06/06/23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	06/06/23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO and EPSOLAY in Canada	06/06/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Sol-Gel Technologies Ltd.

Acciones

SLGL

IL0011417206

Otros idiomas

Filtros